CLINICAL TRIALS PROFILE FOR TRADIPITANT
✉ Email this page to a colleague
Clinical Trials for Tradipitant
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02621385 ↗ | Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects | Completed | Cross Research S.A. | Phase 1 | This study is designed to evaluate the potential effect of administration of tradipitant on CYP3A4 using midazolam pharmacokinetics as markers. The study will also further characterize the pharmacokinetics of tradipitant. |
NCT02621385 ↗ | Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects | Completed | Vanda Pharmaceuticals | Phase 1 | This study is designed to evaluate the potential effect of administration of tradipitant on CYP3A4 using midazolam pharmacokinetics as markers. The study will also further characterize the pharmacokinetics of tradipitant. |
NCT02651714 ↗ | Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis | Completed | Vanda Pharmaceuticals | Phase 2 | This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with treatment-resistant pruritus diagnosed with atopic dermatitis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tradipitant
Condition Name
Clinical Trial Locations for Tradipitant
Trials by Country
Clinical Trial Progress for Tradipitant
Clinical Trial Phase
Clinical Trial Sponsors for Tradipitant
Sponsor Name